Clinical Trials Browser

Phase 2 × Carcinoma, Hepatocellular × Radiation × Clear all

NCT03482102 2026-05-04

Durvalumab (MEDI4736) and Tremelimumab and Radiation Therapy in Hepatocellular Carcinoma and Biliary Tract Cancer

Phase 2 Active not recruiting

Gastrointestinal

Biliary Tract Neoplasms, Carcinoma, Hepatocellular